Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 10, 2008

Dr. Reddy’s and 7TM Pharma Join Forces on Metabolic Disorders

  • Dr. Reddy’s Laboratories signed a drug discovery collaboration agreement with 7TM Pharma to focus on metabolic disorders.The companies will focus on identifying clinical candidates for preselected targets.

    They will jointly develop these candidates from the preclinical stage up to Phase IIa. The firms will then have the option of licensing-out the candidates for further development and commercialization or continuing the joint research collaboration.

    Dr Reddy’s R&D capabilities will be combining with 7TMs background in the GPCR area and the firms platform, Site Directed Drug Discovery®.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »